We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+9.8%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$2.43B
AUM Growth
+$621M
Cap. Flow
+$467M
Cap. Flow %
19.2%
Top 10 Hldgs %
40.6%
Holding
542
New
87
Increased
259
Reduced
104
Closed
41

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$36.9M
2
MSFT icon
Microsoft
MSFT
+$24.3M
3
TMO icon
Thermo Fisher Scientific
TMO
+$19.9M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$19.6M
5
AMZN icon
Amazon
AMZN
+$16.5M

Sector Composition

Rank Sector Weight
1 Technology 21.1%
2 Industrials 16.01%
3 Healthcare 9.99%
4 Financials 9.49%
5 Consumer Discretionary 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPXU icon
476
ProShares UltraPro Short S&P 500
SPXU
$414M
$154K 0.01%
+177
New +$166K
CRON
477
Cronos Group
CRON
$1.08B
$152K 0.01%
30,300
USAC icon
478
USA Compression Partners
USAC
$3.79B
$150K 0.01%
15,000
-4,400
-23% -$49.6K
ETY icon
479
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.26B
$147K 0.01%
13,455
-47,573
-78% -$528K
AMX icon
480
America Movil
AMX
$76B
$142K 0.01%
11,355
HIND
481
Vyome Holdings
HIND
$14.1M
0
PTVE
482
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$127K 0.01%
+10,000
New +$125K
BOE icon
483
BlackRock Enhanced Global Dividend Trust
BOE
$675M
$125K 0.01%
13,014
-36,275
-74% -$352K
BRMK.WS
484
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$124K 0.01%
449,148
SRTY icon
485
ProShares UltraPro Short Russell2000
SRTY
$78.8M
$119K ﹤0.01%
+138
New +$124K
BHR
486
Braemar Hotels & Resorts
BHR
$160M
$105K ﹤0.01%
41,912
IVC
487
DELISTED
Invacare Corporation
IVC
$105K ﹤0.01%
13,988
CNK icon
488
Cinemark Holdings
CNK
$4.22B
$102K ﹤0.01%
+10,200
New +$127K
ORGS
489
DELISTED
Orgenesis Inc. Common Stock
ORGS
$101K ﹤0.01%
2,000
LAB icon
490
Standard BioTools
LAB
$351M
$89K ﹤0.01%
12,000
-11,257
-48% -$77.7K
SM icon
491
SM Energy
SM
$7.58B
$89K ﹤0.01%
55,776
STGW icon
492
Stagwell
STGW
$2.1B
$89K ﹤0.01%
55,500
FLR icon
493
Fluor
FLR
$6.99B
$88K ﹤0.01%
10,000
PNNT
494
Pennant Park Investment Corp
PNNT
$217M
$54K ﹤0.01%
+17,000
New +$56.9K
LYG icon
495
Lloyds Banking Group
LYG
$90.7B
$50K ﹤0.01%
38,561
-513
-1% -$719
SAN icon
496
Banco Santander
SAN
$202B
$40K ﹤0.01%
22,757
+2,280
+11% +$4.9K
RMTI icon
497
Rockwell Medical
RMTI
$28M
$32K ﹤0.01%
+273
New +$47.2K
FTK icon
498
Flotek Industries
FTK
$847M
$27K ﹤0.01%
+1,667
New +$19.4K
CATX icon
499
Perspective Therapeutics
CATX
$341M
$23K ﹤0.01%
4,000
NAK
500
Northern Dynasty Minerals
NAK
$779M
$21K ﹤0.01%
20,954
+7,954
+61% +$10.9K

Similar funds

Cerity Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Cerity Partners held 542 positions worth $2.43B, up 34% from $1.81B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Cerity Partners deployed $467M of net new capital in Q3 2020, opening 87 new positions and adding to 259 existing holdings. Its largest new stake was Dover: 41,600 shares worth $4.51M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard Morningstar Growth ETF, an estimated $16M trimmed.

  • Cerity Partners's largest Q3 2020 buy was Dover: 41,600 shares worth $4.51M.
  • Cerity Partners added most to Apple in Q3 2020, an estimated $36.9M increase.
  • Cerity Partners's biggest Q3 2020 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $16M.
  • Cerity Partners fully exited Schwab US Aggregate Bond ETF in Q3 2020, selling an estimated $7.34M.
  • Cerity Partners's ten largest holdings make up 41% of its $2.43B portfolio in Q3 2020.
  • Cerity Partners opened 87 new positions and closed 41 in Q3 2020.
  • Cerity Partners's portfolio value rose 34% quarter-over-quarter to $2.43B.

Based on Cerity Partners's 13F filing for Q3 2020, filed 12 Nov 2020.